DexCom had 76 patents in internet of things during Q4 2023. DexCom Inc filed patents in Q4 2023 for systems and methods related to continuous analyte measurement in a host’s vascular system. The inventions include features such as power saving sensor electronics, dynamic user interaction modes, and wireless data communication between analyte sensor systems and mobile devices. These innovations aim to improve the accuracy, convenience, and efficiency of continuous glucose monitoring for users. GlobalData’s report on DexCom gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
DexCom grant share with internet of things as a theme is 40% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Analyte sensor (Patent ID: US20230414140A1)
The patent filed by DexCom Inc. relates to systems and methods for continuous analyte measurement in a host's vascular system. The system includes a vascular access device, sensor, and sensor electronics for insertion into the host's circulatory system. The method involves evaluating the sensitivity of an implanted analyte sensor over time by receiving sensor data, calculating sensitivity intermittently, and assessing changes in sensitivity based on multiple time-spaced calculations. The evaluation is done using prior sensitivity information without relying on blood-glucose measurements.
The claims detail the method for evaluating sensitivity changes, including specific time periods for evaluation, averaging and filtering sensitivity measurements, comparing changes with criteria, and using the most recent sensitivity calculation for calibration. The method also involves measuring changes in solute transport of the sensor membrane and auto-calibrating the sensor based on the measured sensitivity changes. The process includes iterative evaluation of sensitivity calculations over time and using a priori sensitivity information throughout the sensor session. Overall, the patent focuses on improving the accuracy and reliability of continuous analyte measurement systems by effectively monitoring and calibrating sensor sensitivity over time.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
